We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Zebra Technologies (ZBRA - Free Report) , builds tracking technology and solutions that generate actionable information and insight, giving companies unprecedented visibility into their businesses by giving physical things a digital voice.Zebra Technologies came out with quarterly earnings per share, beating the Zacks Consensus Estimate. Within the past quarter, the Zacks Consensus Estimate for ZBRA's full-year earnings has moved higher. This is a sign of improving analyst sentiment and a positive earnings outlook trend. Our latest available data shows that ZBRA has returned double digits since the start of the calendar year. Zebra Technologies is performing better than its sector in terms of year-to-date returns.
Boston Beer Co. Inc. (SAM - Free Report) , is one of the largest craft brewers in the United States.Boston Beer outpaced the industry year to date, courtesy of earnings beat in third-quarter 2020 on strong shipments and depletions growth. This marked the tenth straight quarter of double-digit depletions growth, backed by strength in Truly Hard Seltzer and Twisted Tea brands. It expects investing heavily in the Truly brand to enhance the brand’s position in the hard seltzer category. Moreover, it revised depletions and earnings guidance for 2020 based on the trends witnessed in the first nine months and expectations for the remainder of the year, including strong performance for the Truly brand. Additionally, it expects all of its brands to witness growth in 2021.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better. See these 7 breakthrough stocks now>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Top Stock Picks for Week of November 23, 2020
Zebra Technologies (ZBRA - Free Report) , builds tracking technology and solutions that generate actionable information and insight, giving companies unprecedented visibility into their businesses by giving physical things a digital voice.Zebra Technologies came out with quarterly earnings per share, beating the Zacks Consensus Estimate. Within the past quarter, the Zacks Consensus Estimate for ZBRA's full-year earnings has moved higher. This is a sign of improving analyst sentiment and a positive earnings outlook trend. Our latest available data shows that ZBRA has returned double digits since the start of the calendar year. Zebra Technologies is performing better than its sector in terms of year-to-date returns.
Boston Beer Co. Inc. (SAM - Free Report) , is one of the largest craft brewers in the United States.Boston Beer outpaced the industry year to date, courtesy of earnings beat in third-quarter 2020 on strong shipments and depletions growth. This marked the tenth straight quarter of double-digit depletions growth, backed by strength in Truly Hard Seltzer and Twisted Tea brands. It expects investing heavily in the Truly brand to enhance the brand’s position in the hard seltzer category. Moreover, it revised depletions and earnings guidance for 2020 based on the trends witnessed in the first nine months and expectations for the remainder of the year, including strong performance for the Truly brand. Additionally, it expects all of its brands to witness growth in 2021.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>